Skip to content
2000
Volume 4, Issue 1
  • ISSN: 2542-579X
  • E-ISSN: 2542-5803

Abstract

Oral drug delivery systems, including fluoride supplements, constitute one of the most prevalent routes for the administration of medications, playing a crucial role in the treatment and prevention of various diseases, including dental caries. Fluorides, employed as a preventive and control measure against dental caries, are available in two primary forms: Systemic fluorides and topical fluorides. Topical fluorides are found in toothpaste, varnish, gels, mouth rinses, and washes, while systemic fluorides are administered lozenges, tablets, and liquid formulations.

This literature work focuses on the specific challenges associated with fluoride supplement formulations and aims to shed light on potential setbacks. Among these challenges, poor patient compliance, especially in pediatric populations, and the associated risk of underdosing or overdosing, leading to fluorosis, stand out as significant concerns. If left unaddressed, these issues could compromise the efficacy of one of the most effective caries prevention methods available.

The primary objective of this study is to explore advancements in fluoride supplement formulations, with a particular emphasis on addressing the identified challenges, especially for pediatric and geriatric patients. By devising improved formulations tailored to the unique needs of these populations, we aim to mitigate compliance issues and minimize the associated risk factors, thereby strengthening the effectiveness of dental caries prevention strategies. This research endeavors to contribute valuable insights to the field of oral healthcare and pharmaceutical development, ultimately promoting better oral health outcomes for individuals of all ages.

Loading

Article metrics loading...

/content/journals/cdent/10.2174/012542579X258065231114102420
2024-02-02
2025-01-24
Loading full text...

Full text loading...

References

  1. SunilS. SharmaK A.S. Pharmaceutical Jellies: A novel way of drug delivery.J Pharm Sci Res2020127904909
    [Google Scholar]
  2. HellwigE. LennonÁ.M. Systemic versus topical fluoride.Caries Res.200438325826210.1159/00007776415153698
    [Google Scholar]
  3. ManiruzzamanM. BoatengJ.S. ChowdhryB.Z. SnowdenM.J. DouroumisD. A review on the taste masking of bitter APIs: Hot-melt extrusion (HME) evaluation.Drug Dev. Ind. Pharm.201440214515610.3109/03639045.2013.80483323763436
    [Google Scholar]
  4. RiordanP.J. Fluoride supplements for young children: An analysis of the literature focusing on benefits and risks.Community Dent. Oral Epidemiol.1999271728310.1111/j.1600‑0528.1999.tb01994.x10086929
    [Google Scholar]
  5. Montero-PadillaS. VelagaS. MoralesJ.O. Buccal dosage forms: General considerations for pediatric patients.AAPS PharmSciTech201718227328210.1208/s12249‑016‑0567‑227301872
    [Google Scholar]
  6. DriscollW.S. Nowjack-RaymerR. SelwitzR.H. LiS.H. HeifetzS.B. A comparison of the caries-preventive effects of fluoride mouthrinsing, fluoride tablets, and both procedures combined: Final results after eight years.J. Public Health Dent.199252211111610.1111/j.1752‑7325.1992.tb02252.x1564689
    [Google Scholar]
  7. NegiP. SinghB. SharmaG. BegS. KatareO.P. Biocompatible lidocaine and prilocaine loaded-nanoemulsion system for enhanced percutaneous absorption: QbD-based optimisation, dermatokinetics and in vivo evaluation.J. Microencapsul.201532541943110.3109/02652048.2015.104651326066775
    [Google Scholar]
  8. PsimadasD. GeorgouliasP. ValotassiouV. LoudosG. Molecular nanomedicine towards cancer: In-labeled nanoparticles.J. Pharm. Sci.201210172271228010.1002/jps.2314622488174
    [Google Scholar]
  9. DahiyaJ. JalwalP. SinghB. Chewable tablets: A comprehensive review.Pharma Innov J201545100105
    [Google Scholar]
  10. RayC. AroraV. SharmaV. Fast dissolving tablets-a novel drug delivery system for pediatric & geriatric patient.Int Bulletin Drug Res2011125570
    [Google Scholar]
  11. UdaykumarM. NageswaraoA.B. KumarV.T. GiriV.V. Fast dissolving tablets: New fangled drug delivery system, a comprehensive review.Int. J. Drug Deliv.2012231518
    [Google Scholar]
  12. LopezF.L. ErnestT.B. TuleuC. GulM.O. Formulation approaches to pediatric oral drug delivery: Benefits and limitations of current platforms.Expert Opin. Drug Deliv.201512111727174010.1517/17425247.2015.106021826165848
    [Google Scholar]
  13. Covariance structure analysis on health-related indicators in homebound elderly individuals with a focus on the UMDECDE.2015
  14. BibbyB.G. WilkinsE. WitolE. A preliminary study of the effects of fluoride lozenges and pills on dental caries.Oral Surg. Oral Med. Oral Pathol.19558221321610.1016/0030‑4220(55)90195‑X13236309
    [Google Scholar]
  15. HeiligM.L. United States patent office. ACM SIGGRAPH Comput Graph19942821314
    [Google Scholar]
/content/journals/cdent/10.2174/012542579X258065231114102420
Loading

  • Article Type:
    Rapid Communication
Keyword(s): chewable tablets; Fluoride supplements; fluorosis; liquid formulations; lozenges; tooth decay
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test